Pang Jun

25PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCancer cell biologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 14, 2026
Evaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.

|Jul 21, 2026
CD73-LNPs promote antitumor T-cell immunity via amplifying TLR3-mediated immunostimulatory dendritic cell activation.

|Jun 18, 2026
VEGF-C maturation mediated by CircFOCAD-orchestrated CCBE1 and ADAM10 expression in nuclear-cytoplasmic synergy drives lymphatic metastasis.

|Feb 26, 2026
Causal relationships between plasma metabolites and prostate cancer: A Mendelian randomization study exploring immune and inflammatory mediators.

Mengjun Huang, Dong Ning, Tongyu Tong

|Dec 15, 2025
CDK12-Mediated Phosphorylation of FOXA1 Promotes Prostate Cancer Progression via the MDM2-p53 Axis.

Binyuan Yan, Mengjun Huang, Jinxiang Wang

|Aug 29, 2025
Mapping a New Blueprint of Multimodal Immunotherapy Against Prostate Cancer: Breakthroughs, Barriers, and Bold Frontiers.

Yiting Wang, Fei Cao, Mengjun Huang

Pageof 5

Frequent Collaborators

2 joint publications

Jinsheng Huang

2 joint publications

Yupeng Guan

2 joint publications

Binyuan Yan

2 joint publications

Peng Li